CUMI Consol. PAT Sinks 83% YoY to ₹12 Cr on CAAG One-off; Adjusted Profit Up ~25%
PAT -83.2% YoY · revenue +13.2% · margins expanding · beat vs street
₹1,469.05 Cr
+13.2% YoY
₹12.45 Cr
-83.2% YoY
0.84%
-4.8pp YoY
₹0.66
Carborundum Universal's consolidated PAT (owners' share) fell 83.2% YoY to ₹12.45 Cr from ₹74.26 Cr in Q2FY26, and 84.5% QoQ from ₹80.34 Cr in Q1FY27 — but the headline crash is almost entirely a single one-off, not an operating problem. The company recognised an ₹80.26 Cr exceptional charge this quarter for winding down its German step-down subsidiary CUMI Awuko Abrasives GmbH (CAAG): in October 2026 CAAG sold its plant, equipment and inventory for ₹5.34 Cr and settled a reconciliation-of-interest/social plan with employees under German labour law, triggering the write-down. Strip that out and adjusted PAT was ₹92.7 Cr, up ~24.8% YoY and ~15.4% QoQ — management states this explicitly in its press release, and the arithmetic ties out (₹58.02 Cr PBT + ₹80.26 Cr add-back ≈ ₹138.28 Cr pre-exceptional PBT, matching the release's ₹138 Cr figure). Revenue grew a cleaner 13.2% YoY to ₹1,469 Cr (₹1,298 Cr), landing exactly inside the ₹1,450–1,480 Cr range our pre-result preview flagged as the Street's working estimate.
Q2 FY-2027 vs prior quarters
The margin story underneath is actually positive: EBITDA margin expanded to ~12.5% from 12.1% a year ago and a sharply lower 9.5% in Q1FY27, with Ceramics doing the heavy lifting — consolidated Ceramics sales jumped 36.1% YoY to ₹410 Cr and segment PBIT grew 62.1% YoY, well ahead of the 23-25% FY27 growth guidance management had just raised off the back of Q1's strength. Electrominerals also beat its guided 9-10% range, growing consolidated sales 11.1% YoY to ₹443 Cr. Abrasives was the laggard, up just 4.0% YoY to ₹607 Cr on broadly flat sequential sales, pulling blended consolidated growth (13.1-13.2%) a touch below the ~15% overall guidance management had reiterated — on balance this reads as guidance met rather than clearly beaten, since the shortfall traces to one segment rather than broad execution.
The stock went into the print at ₹1,080.3, down 13.7% over the past month of trading.
For context: revenue is at a 6-quarter high.
Consolidated sales could be 15% growth (excl. divested entities). Ceramics upgraded to 23%-25% vs 15%-15.5% prior. Electrominerals 9%-10% excl. Foskor. CAPEX ₹400 Cr maintained.
— This quarter: met
Our pre-result preview flagged that Street consensus (7 analysts, zero Buy ratings, median target ₹964.50 implying 11% downside) was skeptical of the stock's 82x PE and worried any stumble would trigger repricing; this print is a mixed test of that thesis — revenue and adjusted profit both land in-line-to-ahead of the ₹80-90 Cr PAT range the preview cited, but the reported headline miss (₹12.45 Cr) is exactly the kind of noisy print that thin, bearish coverage could misread without parsing the CAAG note. The quarter's other developments were largely incidental to the print: CUMI appointed Sriram Seshadri as CFO & KMP (Sep 7) and CUMI invested $3M in a Cyprus subsidiary (Sep 30) — Cyprus being where CIL, the holding company that approved CAAG's closure, is based, so that infusion plausibly relates to funding the wind-down; several ESG ratings during the quarter carry no financial bearing.
W1
CAAG final liquidation/de-registration in Germany — management does not expect further exceptional charges once this completes.
W2
FY27 guidance delivery: consolidated sales guided ~15% (Ceramics 23-25%, Electrominerals 9-10% ex-Foskor) — Ceramics is running well ahead while Abrasives trails at 4% YoY.
W3
Consolidated net debt at ₹111 Cr (debt ₹362 Cr, cash ₹251 Cr ex-VAW) against H1FY27 capex of ₹127 Cr and a full-year ₹400 Cr capex plan.
Momentum vs Valuation: Can Ceramics Execute at 25% Growth?
CUMI heads into Q2 with upgraded FY27 guidance on ceramics strength and Q1's 23% profit growth, but analyst consensus remains skeptical on valuation. The quarter will test whether operational momentum can justify the elevated 82x PE.
The Setup: Momentum vs. Street Skepticism
Carborundum Universal enters Q2 FY27 with a rare tailwind: in August, CUMI raised its full-year ceramics sales guidance to 25% growth, citing strong demand across abrasives and refractories. Q1's blended numbers supported the bullish narrative—consolidated revenue +17% YoY to ₹1,427 Cr, profit +23% to ₹76.4 Cr, with margins expanding. Yet the Street remains skeptical. Analyst consensus is Sell, with a median target of ₹964.50 (11% downside from current ₹1,129), anchored on valuation: the stock trades at 82x trailing PE, well above the industrials peer average of ~24x. This quarter will test two competing narratives: can operational execution justify the premium, or does the valuation signal a peak?
~₹1,450–1,480 Cr
Q1 was ₹1,427 Cr; +17% YoY run-rate suggests mid-teens sequential growth on normal seasonals
₹80–90 Cr
Q1 PAT of ₹76.4 Cr grew +23% YoY; on-plan trajectory tracks ₹330–340 Cr for full year
Tracking 25% FY27
Raised guidance in Q1; abrasives and refractories momentum is the growth engine
EBITDA & PAT margin
Q1 margins expanded; the swing factor is raw material cost and operating leverage in a growing quarter
A strong Q2 would mean: revenue growth holding in the mid-to-high teens (₹1,450+ Cr), PAT in the ₹85–90 Cr range with margin holding or expanding, and ceramics segment metrics tracking the 25% guidance. Any evidence of demand stalling, margin compression, or guidance trimming would be a weak print and hand ammunition to the skeptics.
Tracking Guidance: Is Full Year On Course?
CUMI's raised FY27 guidance is unusual; it signals management confidence but also raises the bar. The August guidance raise (ceramics to 25%) was tied to continued strong demand in abrasives and refractories—a bet that industrial cycles and capex momentum will hold. Q1 delivered; Q2 will be the second proof point. For the full year to land, CUMI needs the next two quarters (Q2 and Q3) to hold growth momentum. Any slowdown now in forward orders, pricing power, or input costs becomes a material risk to guidance and, by extension, to the Street's downside case.
Since Last Quarter: Business Updates & Risk Items
CFO change: Sriram Seshadri appointed CFO (effective Sept 7) — a leadership transition that markets typically monitor for capital allocation shifts. No guidance change has been signaled yet.
Cyprus investment: CUMI infused $3M (~₹28.8 Cr) into wholly-owned subsidiary CUMI International (Cyprus) in late September, signaling international expansion and capex discipline.
ESG & governance: CUMI filed BRSR for FY26 and received ESG ratings from NSE, CRISIL, and Niche Ninety Nine—routine disclosures, no red flags.
Trading window: Closed Oct 1–Nov 4 ahead of result announcement, per insider-trading code. Standard procedure; no material pledges or insider activity flagged.
What to Watch on Result Day (Nov 2)
1 · Revenue growth & mix
Watch for absolute revenue (expect ₹1,450–1,480 Cr) and segment breakout (ceramics pacing 25% guidance?). Any miss or miss vs. Q1's +17% would signal demand softness. Pricing action and volume trends matter.
2 · Margin trajectory
EBITDA margin (%) and PAT margin. Q1 expanded; if Q2 holds or expands further, it reinforces execution quality and raw-material tailwinds. Compression would hint at cost inflation or mix headwinds.
3 · FY27 guidance reaffirm/trim
Management will likely reaffirm or adjust the ceramics 25% and full-year targets. Any trim triggers immediate repricing on valuation concerns; a reaffirm with strong Q2 numbers could spark a relief rally despite the Sell consensus.
CUMI is in the rare position of delivering strong operational momentum while trading at stratospheric valuation—a combination that invites skepticism. Q1's 23% profit growth and August's guidance raise proved management's conviction, but the Street's Sell consensus reflects a belief that the cycle will turn or the premium will compress. Q2 is the test: does CUMI show that the 25% ceramics guidance is sustainable, margins are durable, and execution merits the 82x multiple? Or does reality start to fade the narrative? With the trading window closing on Nov 4 and the board meeting on Nov 2, the market will be watching for any signal that the story is running out of steam.
For investors, the key is the margin trend and forward orders commentary. If CUMI can hold high-single-digit margin expansion and ceramics orders remain robust, the valuation case has legs. If not, the downside scenario (trading back to consensus target and the low ₹870s) comes into focus.